Lynryl- PM2 (10x10 T)

Composition

Glimepiride 2 mg + Metformin Hydrochloride (SR) 500mg, & Pioglitazone Hydrochloride 15 mg Bilayered Tab

Lynryl-PM2 Tablets contain a combination of Glimepiride, Pioglitazone, and Metformin (Sustained Release), formulated to help manage Type 2 Diabetes Mellitus in adults. This triple-action therapy helps improve blood sugar control by increasing insulin sensitivity, stimulating insulin release, and reducing glucose production in the liver.

Key Benefits

- Helps maintain healthy blood glucose levels.

- Improves insulin sensitivity and glucose utilization.

- Supports long-term glycemic control.

- Sustained-release formulation provides prolonged therapeutic action.

- Helps reduce the risk of diabetes-related complications when used alongside a healthy diet and regular exercise.